Cargando…

Recombinant FVIII: the milestone of modern hemophilia treatment

Detalles Bibliográficos
Autor principal:	Mannucci, Pier Mannuccio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2023
Materias:	Landmark Paper in Hematology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153518/ https://www.ncbi.nlm.nih.gov/pubmed/37128816 http://dx.doi.org/10.3324/haematol.2023.282874

Ejemplares similares

Fc-fusion technology and recombinant FVIII and FIX in the management of the hemophilias
por: Mancuso, Maria Elisa, et al.
Publicado: (2014)

The first achievement of complete remission in childhood leukemia by treatment with the folic acid antagonist aminopterin
por: Izraeli, Shai
Publicado: (2022)

t(15;17) in acute promyelocytc leukemia
por: Ling, Victoria Y., et al.
Publicado: (2023)

The development of graft-versus-host disease prophylaxis
por: Cutler, Corey
Publicado: (2023)

The GPIIb-IIIa defect of platelets in Glanzmann thrombasthenia
por: Nurden, Alan T.
Publicado: (2023)

The International Prognostic Index: still relevant 30 years later
por: LaCasce, Ann S.
Publicado: (2023)

TCF3::HLF acute lymphoblastic leukemia: still challenging to cure thirty years later
por: Tasian, Sarah K.
Publicado: (2023)

The French-American-British classification of myelodysplastic syndromes
por: Mittelman, Moshe
Publicado: (2023)

When more is just more, not better: a recurring lesson
por: Smith, Sonali M.
Publicado: (2023)

The International Prognostic Index in aggressive B-cell lymphoma
por: Maurer, Matthew J.
Publicado: (2023)

Chasing quality remission in acute myeloid leukemia: intensity of induction and residual disease
por: Ofran, Yishai
Publicado: (2023)

Clonal evolution of leukemia from G6PD studies
por: Bacharach, Tal, et al.
Publicado: (2023)

The platelet aggregometer
por: Balduini, Carlo L.
Publicado: (2022)

Another Philadelphia story*
por: Radich, Jerald P.
Publicado: (2022)

Proteasome inhibition: the dawn of novel therapies in multiple myeloma
por: Engelhardt, Monika, et al.
Publicado: (2022)

The “7+3” regimen in acute myeloid leukemia
por: Rowe, Jacob M.
Publicado: (2022)

Post-transplant cyclophosphamide: overcoming the HLA barrier to hematopoietic stem cell transplants
por: Bacigalupo, Andrea
Publicado: (2022)

Graft-versus-host disease in allogeneic transplantation: the good and the bad
por: Kröger, Nicolaus-Martin
Publicado: (2022)

The beginnings of molecular medicine
por: Rees, David C.
Publicado: (2022)

The polymerase chain reaction, so simple, so clever: the discovery that made minimal residual disease come true
por: Cavé, Hélène
Publicado: (2022)

How we changed our approach to venous thromboembolism
por: Ageno, Walter
Publicado: (2022)

What doesn’t kill you makes you stronger – bcl-2 promotes survival independent of proliferation
por: Schimmer, Aaron D.
Publicado: (2022)

Generation of the first monoclonal antibody using mouse hybridomas
por: Falini, Brunangelo
Publicado: (2022)

A Case of Acquired Hemophilia A and Congenital Hemophilia B
por: Fortier, Julia C, et al.
Publicado: (2022)

Hemophilia therapy: the future has begun
por: Mannucci, Pier Mannuccio
Publicado: (2020)

Review of Potential Barriers to Effective Hemostatic Management of Acquired Hemophilia A by Non-Hemophilia Experts in the United States
por: Sharathkumar, Anjali, et al.
Publicado: (2023)

Aging with Hemophilia: The Challenge of Appropriate Drug Prescription
por: Mannucci, Pier Mannuccio
Publicado: (2019)

Acquired Hemophilia A (FVIII Deficiency) Associated with Papillary Thyroid Cancer: Treatment with Recombinant Porcine FVIII
por: Nguyen, S., et al.
Publicado: (2019)

An Interesting Case of Acquired Hemophilia A in an Elderly Patient Presenting with Hematuria
por: Mehta, Parth, et al.
Publicado: (2020)

The management of hemophilia in elderly patients
por: Franchini, Massimo, et al.
Publicado: (2007)

Past, present and future of hemophilia: a narrative review
por: Franchini, Massimo, et al.
Publicado: (2012)

Markedly Reduced FVIII Recovery Associated with Anti-FVIII Peg Antibodies after BNT162b2 Sars-Cov-2 Vaccination
por: Valsecchi, Carla, et al.
Publicado: (2022)

Reduced FVIII recovery associated with anti-FVIII PEG antibodies after BNT162b2 SARS-CoV-2 vaccination
por: Valsecchi, Carla, et al.
Publicado: (2022)

How we manage cardiovascular disease in patients with hemophilia
por: Franchini, Massimo, et al.
Publicado: (2023)

The psychology of social class: How socioeconomic status impacts thought, feelings, and behaviour
por: Manstead, Antony S. R.
Publicado: (2018)

Science as collaborative knowledge generation
por: Ellemers, Naomi
Publicado: (2020)

Addressing workplace gender inequality: Using the evidence to avoid common pitfalls
por: Ryan, Michelle K.
Publicado: (2022)

Comparative evaluation of the safety and efficacy of recombinant FVIII in severe hemophilia A patients
por: Abolghasemi, Hassan, et al.
Publicado: (2018)

Co-administration of FVIII with IVIG reduces immune response to FVIII in hemophilia A mice
por: Afraz, Sajjad, et al.
Publicado: (2022)

Spontaneous intramural hemorrhage in a patient with severe hemophilia A
por: Shan, Ken-Hsyuan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rm8f2mm92rqgjmtvbflpsv59gb